These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9142067)

  • 1. Decline in deaths from AIDS due to new antiretrovirals.
    Hogg RS; O'Shaughnessy MV; Gataric N; Yip B; Craib K; Schechter MT; Montaner JS
    Lancet; 1997 May; 349(9061):1294. PubMed ID: 9142067
    [No Abstract]   [Full Text] [Related]  

  • 2. Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.
    Monpoux F; Sirvent N; Cottalorda J; Mariani R; Lefbvre JC
    AIDS; 1997 Oct; 11(12):1523-5. PubMed ID: 9342078
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data in from first head-to-head protease inhibitor.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
    [No Abstract]   [Full Text] [Related]  

  • 6. Viracept combination studies.
    AIDS Patient Care STDS; 1998 Jun; 12(6):495-6. PubMed ID: 11362002
    [No Abstract]   [Full Text] [Related]  

  • 7. 3-drug therapy reduces deaths and new AIDS-related illnesses by 50%.
    Baker R
    BETA; 1997 Mar; ():3-4. PubMed ID: 11364527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.
    Rockstroh JK; Theisen A; Kaiser R; Sauerbruch T; Spengler U
    AIDS; 1998 May; 12(7):829-30. PubMed ID: 9619824
    [No Abstract]   [Full Text] [Related]  

  • 9. Study shows three drugs better than two.
    AIDS Alert; 1997 Apr; 12(4):39. PubMed ID: 11364145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
    Lallemand F; Adda N; Schneider V; Jacomet C; Salhi Y; Rozenbaum W
    Clin Infect Dis; 1999 May; 28(5):1184-5. PubMed ID: 10452672
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral therapy: a guide to the most important trials.
    Rutschmann O; Hirschel B
    Schweiz Med Wochenschr; 1997 Mar; 127(11):436-43. PubMed ID: 9098917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P
    Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of disseminated molluscum contagiosum with Highly Active Anti-Retroviral Therapy (HAART) in patients with AIDS.
    Calista D; Boschini A; Landi G
    Eur J Dermatol; 1999; 9(3):211-3. PubMed ID: 10210787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly active antiretroviral therapy: progress and pitfalls.
    Wood LV
    J Pediatr; 1999 Dec; 135(6):655-7. PubMed ID: 10586162
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
    Michelet C; Bellissant E; Ruffault A; Arvieux C; Delfraissy JF; Raffi F; Bazin C; Renard I; Sébille V; Chauvin JP; Dohin E; Cartier F
    Clin Pharmacol Ther; 1999 Jun; 65(6):661-71. PubMed ID: 10391672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial.
    Foudraine NA; Jurriaans S; Weverling GJ; Burger DM; Hoetelmans RM; Roos MT; Maas J; Miedema F; Reiss P; Portegies P; de Wolf F; Lange JM
    Antivir Ther; 2001 Mar; 6(1):55-62. PubMed ID: 11417762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3.
    Losso MH; Belloso WH; Emery S; Benetucci JA; Cahn PE; Lasala MC; Lopardo G; Salomon H; Saracco M; Nelson E; Law MG; Davey RT; Allende MC; Lane HC
    J Infect Dis; 2000 May; 181(5):1614-21. PubMed ID: 10823761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete regression of AIDS-related Kaposi's sarcoma-associated human herpesvirus-8 during therapy with indinavir.
    Martinelli C; Zazzi M; Ambu S; Bartolozzi D; Corsi P; Leoncini F
    AIDS; 1998 Sep; 12(13):1717-9. PubMed ID: 9764794
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustiva combination effective as initial treatment.
    AIDS Patient Care STDS; 1998 Oct; 12(10):801-2. PubMed ID: 11362026
    [No Abstract]   [Full Text] [Related]  

  • 20. d4T+AZT--unexpected CD4 drop seen in study.
    AIDS Treat News; 1996 Dec; (No 261):1. PubMed ID: 11364024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.